882
Views
119
CrossRef citations to date
0
Altmetric
Reviews

Native albumin for targeted drug delivery

, , , , , & show all
Pages 915-925 | Published online: 30 Jun 2010

Bibliography

  • Peters TJ. All about albumin. Biochemistry, genetics, and medical applications 1996. Academic Press, New York; 1996
  • Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:F23-6
  • Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981;24:1550-60
  • Ballantyne FC, Fleck A, Dick WC. Albumin metabolism in rheumatoid arthritis. Ann Rheum Dis 1971;30:265-70
  • Niwa Y, Iio A, Niwa G, Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer. J Clin Lab Immunol 1990;31:11-6
  • Stehle G, Sinn H, Wunder A, The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats. Anticancer Drugs 1997;8:677-85
  • Kremer P, Wunder A, Sinn H, Laser-induced fluorescence detection of malignant gliomas using fluorescein-labeled serum albumin: experimental and preliminary clinical results. Neurol Res 2000;22:481-9
  • Kang H, Alam MR, Dixit V, Cellular delivery and biological activity of antisense oligonucleotides conjugated to a targeted protein carrier. Bioconjug Chem 2008;19:2182-8
  • Temming K, Meyer DL, Zabinski R, Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative. Mol Pharm 2007;4:686-94
  • Dosio F, Arpicco S, Stella B, Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm 2009;382:117-23
  • Melgert BN, Weert B, Schellekens H, The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells. J Drug Target 2003;11:1-10
  • Melgert BN, Olinga P, Jack VK, Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells. J Hepatol 2000;32:603-11
  • Maeda H, Wu J, Sawa T, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-84
  • Jain RK. Delivery of molecular and cellular medicine to solid tumors. J Control Release 1998;53:49-67
  • Chu BC, Fan CC, Howell SB. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. J Natl Cancer Inst 1981;66:121-4
  • Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008;132:171-83
  • Wunder A, Stehle G, Sinn H, Enhanced albumin uptake by rat tumors. Int J Oncol 1997;11:497-507
  • Hartung G, Stehle G, Sinn H, Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. Clin Cancer Res 1999;5:753-9
  • Weigand M, Hartung G, Roboz J, Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone. Anticancer Drug Des 2001;16:227-37
  • Hartung G, Heeger T, Bertsch T, Adaption and clinical evaluation of a homogenous enzyme multiplied immunoassay technique (EMIT) for drug monitoring of a methotrexate-albumin conjugate (MTX-HSA) in humans. Onkologie 2000;23:352-7
  • Fiehn C, Kratz F, Sass G, Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis 2008;67:1188-91
  • Gradishar WJ. Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 2006;7:1041-53
  • EMEA. Available from: http://www.ema.europa.euhumandocs/Humans/EPAR/abraxane/abraxane.htm
  • Schulte S. Use of albumin fusion technology to prolong the half-life of recombinant factor VIIa. Thromb Res 2008;122(Suppl 4):S14-19
  • Melder RJ, Osborn BL, Riccobene T, Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. Cancer Immunol Immunother 2005;54:535-47
  • Rustgi VK. Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C. Curr Med Res Opin 2009;25:991-1002
  • Esmaeili F, Dinarvand R, Ghahremani MH, Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies. J Pharm Sci 2009;98:2718-30
  • Tanaka T, Shiramoto S, Miyashita M, Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Int J Pharm 2004;277:39-61
  • Wosikowski K, Biedermann E, Rattel B, In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin Cancer Res 2003;9:1917-26
  • Eschen N, Bauder-Wust U, Frei E, Aminopterin-human serum albumin conjugate (AP-HSA): uptake and cytotoxic effects in tumor cell lines. Int J Clin Pharmacol Ther 2002;40:564-6
  • Burger AM, Hartung G, Stehle G, Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo. Int J Cancer 2001;92:718-24
  • Wunder A, Stehle G, Schrenk HH, Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma. Int J Cancer 1998;76:884-90
  • Vis AN, van der Gaast A, van Rhijn BW, A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemother Pharmacol 2002;49:342-5
  • Wolff D, Frei E, Hofmeister N, Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease. Transplantation 2006;82:527-33
  • Fiehn C, Muller-Ladner U, Gay S, Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX. Rheumatology (Oxford) 2004;43:1097-105
  • Wunder A, Muller-Ladner U, Stelzer EH, Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. J Immunol 2003;170:4793-801
  • Fiehn C, Neumann E, Wunder A, Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo. Ann Rheum Dis 2004;63:884-6
  • Kremer P, Hartung G, Bauder-Wust U, Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats. Anticancer Drugs 2002;13:615-23
  • Garmann D, Warnecke A, Kalayda GV, Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells. J Control Release 2008;131:100-6
  • Schmid B, Chung DE, Warnecke A, Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy. Bioconjug Chem 2007;18:702-16
  • Schmid B, Warnecke A, Fichtner I, Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library. Bioconjug Chem 2007;18:1786-99
  • Unger C, Haring B, Medinger M, Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin. Clin Cancer Res 2007;13:4858-66
  • Wooley PH. Collagen-induced arthritis in the mouse. Methods Enzymol 1988;162:361-73
  • Neumann E, Judex M, Kullmann F, Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther 2002;9:1508-19
  • Muller-Ladner U, Kriegsmann J, Franklin BN, Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15
  • Lefevre S, Knedla A, Tennie C, Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-20
  • Kremer P, Mahmoudreza F, Ding R, Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery 2009;64:53-60; discussion 60-51
  • Chen K, Xie J, Chen X. RGD-human serum albumin conjugates as efficient tumor targeting probes. Mol Imaging 2009;8:65-73
  • Amthor H, Egelhof T, McKinnell I, Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 2004;14:791-6
  • Clorius JH, Sinn H, Manke HG, Serum albumin (SA) accumulation by bronchogenic tumours: a tracer technique may help with patient selection for SA-delivered chemotherapy. Eur J Nucl Med 1995;22:989-96
  • Becker MD, Nobiling R, Planck SR, Rosenbaum JT. Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis. J Immunol Methods 2000;240:23-37
  • Simi CK, Abraham TE. Nanocomposite based on modified TiO2-BSA for functional applications. Colloids Surf B Biointerfaces 2009;71:319-24
  • Tracey BM, Shuker DE. Characterization of azo coupling adducts of benzenediazonium ions with aromatic amino acids in peptides and proteins. Chem Res Toxicol 1997;10:1378-86
  • Hanstein WG, Hatefi Y, Kiefer H. Radiochemical synthesis and photochemical properties of the uncoupler 2-azido-4-nitrophenol, a versatile photoaffinity labeling reagent. Biochemistry 1979;18:1019-25
  • Murtaza Z, Herman P, Lakowicz JR. Synthesis and spectral characterization of a long-lifetime osmium (II) metal-ligand complex: a conjugatable red dye for applications in biophysics. Biophys Chem 1999;80:143-51

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.